Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMICTAL XR in PGTC Seizures
NCT00104416Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of lamotrigine in generalized tonic-clonic seizure (GTCS), sponsored by GSK. Started Dec 2004; status: completed.
02
Drugs
lamotrigine
03
Conditions
generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on NCT00104416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104416.